CIK: 0001668029 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: May 17, 2021
Total Value ($000): $34,402
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LUNG | PULMONX CORP | 303,030 | $20,915 | 60.8% | $48.97 | 0.0% | — | 745848101 |
| AVIR | ATEA PHARMACEUTICALS INC | 300,000 | $12,534 | 36.4% | $32.23 | 0.0% | — | 04683R106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $882 | 2.6% | $7.87 | — | — | 00773J103 |
| — | DIFFUSION PHARMACEUTICALS IN | 89,848 | $71 | 0.2% | $0.79 | — | — | 253748305 |